SALLY HERRING: Open Payments
NPI 1174175962 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,732 in 67 payments from 9 companies in 2025. Trend: 2023 $1,918 · 2024 $2,523 · 2025 $2,732
Food & beverage: $2,648Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $1,135 |
| Janssen Biotech, Inc. | 6 | $480 |
| Madrigal Pharmaceuticals | 10 | $288 |
| EVOKE PHARMA, INC. | 5 | $194 |
| Ardelyx, Inc. | 4 | $186 |
| Gilead Sciences, Inc. | 8 | $151 |
| Novo Nordisk Inc | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $53 |
Products named: SKYRIZI, TREMFYA, RINVOQ, REZDIFFRA, GIMOTI, IBSRELA, VOQUEZNA, Epclusa.
Industry payments across TX — which companies pay providers there.
